%0 journal article
%@ 0887-2333
%A Lau, S., Rangarajan, R., Philidet, C., Krüger-Genge, A., Braune, S., Kammerer, S., Küpper, J., Lendlein, A., Jung, F.

%D 2020
%J Toxicology in Vitro

%P 104685 
%R doi:10.1016/j.tiv.2019.104685
%T Effects of acrolein in comparison to its prodrug cyclophosphamide on human primary endothelial cells in vitro
%U https://doi.org/10.1016/j.tiv.2019.104685
 
%X High doses of acrolein led to HUVEC death and loss of vWF production. This effect might be associated with the increased incidence of thromboembolic events in cancer patients treated with high doses of CPA.